Zombie AquaTM Fixable Viability Kit and 1 more item

The University of Virginia awarded a purchase order (PO-0449557) to BioLegend Inc. on June 16, 2026, valued at $206.00. This contract, issued in Virginia, covers the procurement of specialized laboratory reagents and diagnostic kits required for research and biomedical applications. The awarded products consist of two distinct line items: one unit of Zombie AquaTM Fixable Viability Kit priced at $62.30 and one unit of Recombinant Human Interleukin-1 Beta (carrier-free) priced at $144.20. Both items are designated for delivery to Mary Grachus Harp.

BioLegend Inc. serves as the prime contractor responsible for fulfilling this purchase order. The products specified are reagent-based materials commonly utilized in cell biology and immunology research. While the specific performance period is not explicitly documented in the award materials, the June 16, 2026 award date represents the contract execution date. The cumulative contract value of $206.00 reflects a straightforward transactional purchase order rather than a comprehensive service contract, indicating a one-time procurement of laboratory supplies for the University of Virginia's research operations.